申请人:3M Innovative Properties Company
公开号:US06677347B2
公开(公告)日:2004-01-13
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
含有醚和磺胺基或磺胺酰胺功能团在1位的咪唑喹啉和四氢咪唑喹啉化合物可作为免疫应答调节剂。该发明的化合物和组合物可以诱导各种细胞因子的生物合成,并且在治疗包括病毒性疾病和肿瘤性疾病在内的各种疾病中具有用途。